for the management of polymyalgia rheumatica (PMR) Target population: Patients with PMR based on clinician diagnosis which may be supported by currently available diagnostic or classification criteria Overarching principles for the management of PMR: A. Adoption of a safe and specific approach to ascertain the PMR case definition. The clinical evaluation should be directed toward exclusion of relevant mimicking (eg, non-inflammatory, inflammatory (such as giant cell arteritis or rheumatoid arthritis), drug-induced, endocrine, infective and neoplastic) conditions. B. Every case of PMR should have the following assessments prior to the prescription of therapy (primary or secondary care): " Documentation of a basic laboratory dataset. This will help to exclude mimicking conditions and establish a baseline for monitoring of therapy. This should include rheumatoid factor and/or anti-cyclic citrullinated peptide antibodies (ACPA), C-reactive protein and/or erythrocyte sedimentation rate